Efficacy of fevogrit in treatment of fever
Phase 4
- Conditions
- Health Condition 1: R509- Fever, unspecified
- Registration Number
- CTRI/2024/02/063022
- Lead Sponsor
- Patanjlai Research Foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Both gender with age limit 18 to 60 years
Body temperature more than 99°F (37.2°C)
Willing to participate and give consent for the study
Exclusion Criteria
Subject on antipyretic, antibiotic, and steroidal medication within the previous 8-12 hours
Any acute or chronic condition that would limit the ability of the patient to participate in the study (Renal, Cardiac disease, Liver disease, or hematologic disorders, bronchial asthma, peptic ulcer disease, and frequent vomiting)
Any condition the investigator identifies that can confound the participants ability to properly participate in the study
Pregnancy or lactation, intention to pregnancy
Known case of Hypothyroidism & Endocrine disease condition.
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in fever in the first four hours after the first dose of fevogritTimepoint: Baseline 1hr 2hr 3hr 4hr 8hr <br/ ><br>Day 2 <br/ ><br>Day 3
- Secondary Outcome Measures
Name Time Method First occurrence of normal temperature <br/ ><br>Timepoint: Day 1 <br/ ><br>Day 2 <br/ ><br>Day 3